Tenet Healthcare (NYSE:THC) Given New $252.00 Price Target at Guggenheim

Key Points

• Guggenheim trimmed its price target on Tenet from $283 to $252 but kept a "buy" rating, and the stock's consensus analyst target (~$244.56) implies roughly a ~37% upside from the prior close.
• Q1 EPS beat — Tenet reported $4.82 EPS vs. $4.21 expected while revenue slightly missed ($5.37B vs. $5.39B); management gave FY‑2026 EPS guidance of $16.38–$18.68 and is expanding higher‑margin outpatient exposure with ~$125M deployed to seven ASC acquisitions.
• Insiders sold about 46,517 shares (~$10.94M) last quarter even as institutional investors hold ~95.4% of the stock, reflecting heavy institutional ownership amid recent insider liquidity.

Tenet Healthcare (NYSE:THC - Get Free Report) had its price objective reduced by stock analysts at Guggenheim from $283.00 to $252.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Guggenheim's price target suggests a potential upside of 37.16% from the company's previous close.

A number of other analysts have also recently commented on the company. UBS Group upped their price target on Tenet Healthcare from $260.00 to $288.00 and gave the company a "buy" rating in a research note on Thursday, February 12th. Wall Street Zen cut Tenet Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, April 25th. Weiss Ratings reissued a "buy (b-)" rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Wells Fargo & Company lowered their target price on Tenet Healthcare from $265.00 to $213.00 and set an "overweight" rating for the company in a research note on Friday. Finally, Jefferies Financial Group increased their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a "buy" rating in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $244.56.

Tenet Healthcare Trading Up 3.7%

Shares of THC stock traded up $6.61 on Friday, reaching $183.73. The company had a trading volume of 719,746 shares, compared to its average volume of 1,127,421. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The stock has a market cap of $16.10 billion, a PE ratio of 11.88, a PEG ratio of 1.35 and a beta of 1.49. The company has a 50-day moving average of $207.31 and a 200-day moving average of $204.17. Tenet Healthcare has a 12 month low of $145.27 and a 12 month high of $247.21.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts' consensus estimates of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analysts' expectations of $5.39 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare's revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities analysts forecast that Tenet Healthcare will post 17.31 earnings per share for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares of the company's stock, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 46,517 shares of company stock valued at $10,943,111 in the last quarter. 0.81% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of THC. Wedmont Private Capital grew its position in Tenet Healthcare by 2.5% during the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company's stock worth $422,000 after acquiring an additional 50 shares during the last quarter. Baron Wealth Management LLC grew its position in Tenet Healthcare by 4.8% during the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company's stock worth $227,000 after acquiring an additional 52 shares during the last quarter. Sagespring Wealth Partners LLC grew its position in shares of Tenet Healthcare by 3.6% in the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company's stock worth $313,000 after buying an additional 55 shares during the last quarter. Quadrant Capital Group LLC grew its position in shares of Tenet Healthcare by 0.7% in the 4th quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company's stock worth $1,616,000 after buying an additional 58 shares during the last quarter. Finally, Syon Capital LLC grew its position in shares of Tenet Healthcare by 5.3% in the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company's stock worth $249,000 after buying an additional 63 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 earnings beat consensus — Tenet reported $4.82 EPS vs. ~$4.21 expected, beating estimates and demonstrating solid profitability and margin control. Zacks: Q1 Earnings Top Estimates
• Positive Sentiment: Big push into ASCs — Tenet deployed ~$125M to acquire seven ASCs in Q1, signaling a strategic shift toward higher-margin outpatient care that should support long-term revenue mix improvement and margin expansion. Becker's ASC: $125M on 7 ASC acquisitions
• Positive Sentiment: ASC acuity and service expansion — Tenet is seeing double-digit joint replacement growth and runs 150+ robotic surgery programs, which supports higher-acuity outpatient volume and revenue per case over time. Becker's ASC: ASC acuity push paying off
• Positive Sentiment: Management execution praised — Management attributed navigating Q1 volume variability to disciplined operations, which investors view as supportive of margins and cash flow. FierceHealthcare: Met Q1's volume curveballs
• Neutral Sentiment: FY‑2026 guidance provided — Tenet issued EPS guidance of roughly $16.38–$18.68 (consensus ~17.22) and revenue guidance centered near consensus, leaving room for interpretation but giving investors forward visibility. Yahoo Finance: Q1 2026 Earnings Call Summary
• Negative Sentiment: Revenue slight miss and admissions/payer-mix headwinds — Revenue came in a touch below estimates (~$5.37B vs. $5.39B expected) and management cited an unfavorable admissions mix and external disruptions that weighed on top-line performance. Benzinga: Blames admissions mix for soft Q1 sales

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.